RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
Implantation of a polycaprolactone scaffold with subchondral bone anchoring ameliorates nodules formation and other tissue alterations
Purpose: Articular cartilage has limited repair capacity. Two different implant devices for articular cartilage regeneration
were tested in vivo in a sheep model to evaluate the effect of subchondral bone anchoring for tissue
repair.
Methods: The implants were placed with press-fit technique in a cartilage defect after microfracture surgery in
the femoral condyle of the knee joint of the sheep and histologic and mechanical evaluation was done 4.5 months
later. The first group consisted of a biodegradable polycaprolactone (PCL) scaffold with double porosity. The second
test group consisted of a PCL scaffold attached to a poly(L-lactic acid) (PLLA) pin anchored to the subchondral
bone.
Results: For both groups most of the defects (75%) showed an articular surface that was completely or almost
completely repaired with a neotissue. Nevertheless, the surface had a rougher appearance than controls and the
repair tissue was immature. In the trials with solely scaffold implantation, severe subchondral bone alterations
were seen with many large nodular formations. These alterations were ameliorated when implanting the scaffold
with a subchondral bone anchoring pin.
Discussions: The results show that tissue repair is improved by implanting a PCL scaffold compared to solely microfracture
surgery, and most importantly, that subchondral bone alterations, normally seen after microfracture
surgery, were partially prevented when implanting the PCL scaffold with a fixation system to the subchondral
bone., This work was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) through the MAT2013-46467-C4-R project (including FEDER financial support). CIBER-BBN is an initiative funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program. CIBER actions are financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund.